Literature DB >> 18550343

Antimicrobial resistance: international control strategies, with a focus on limited-resource settings.

Carlos A Diazgranados1, Denise M Cardo, John E McGowan.   

Abstract

Microorganisms resistant to multiple anti-infective agents have increased worldwide. These organisms threaten both optimal care of patients with infection as well as the viability of current healthcare systems. In addition, antimicrobials are valuable resources that enhance both prevention and treatment of infections. As resistance diminishes this resource, it is a societal goal to minimise resistance and therefore to reduce forces that produce resistance. This review considers strategies for minimising resistance that are needed at several different levels of responsibility, ranging from the patient care provider to international agencies. It then describes responses that might be appropriate according to the resources available for control, focusing on limited-resource settings. Antimicrobial resistance represents an international concern. Response to this problem demands concerted efforts from multiple sectors both in developed and developing countries, as well as the strengthening of multinational/international partnerships and regulations. Both medical and public health agencies should be in the forefront of these efforts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550343     DOI: 10.1016/j.ijantimicag.2008.03.002

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  6 in total

Review 1.  Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias.

Authors:  Q Q Wan; Q F Ye; H Yuan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-12       Impact factor: 3.267

2.  The Impact of an Antibiotic Stewardship Program on the Consumption of Specific Antimicrobials and Their Cost Burden: A Hospital-wide Intervention.

Authors:  Dena Firouzabadi; Ali Akbari; Laleh Mahmoudi; Alireza Sepasian
Journal:  Risk Manag Healthc Policy       Date:  2020-09-23

3.  Impact of treatment heterogeneity on drug resistance and supply chain costs.

Authors:  Eirini Spiliotopoulou; Maciej F Boni; Prashant Yadav
Journal:  Socioecon Plann Sci       Date:  2013-09       Impact factor: 4.923

Review 4.  The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock.

Authors:  Aurora Pop-Vicas; Steven M Opal
Journal:  Virulence       Date:  2013-08-27       Impact factor: 5.882

5.  Antimicrobial resistance (AMR) and plant-derived antimicrobials (PDAms) as an alternative drug line to control infections.

Authors:  Jatin Srivastava; Harish Chandra; Anant R Nautiyal; Swinder J S Kalra
Journal:  3 Biotech       Date:  2013-10-23       Impact factor: 2.406

Review 6.  Addressing Antimicrobial Resistance: An Overview of Priority Actions to Prevent Suboptimal Antimicrobial Use in Food-Animal Production.

Authors:  Guillaume Lhermie; Yrjö T Gröhn; Didier Raboisson
Journal:  Front Microbiol       Date:  2017-01-06       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.